An exciting Project-ALS funded study on the involvement of the gene TDP-43 in ALS-frontotemporal dementia. Understanding how TDP-43 contributes to neurodegeneration will help direct therapeutic efforts. Read here
Last month, Coach John Campo and Gettysburg Bullets Baseball held their annual “Take ALS Yard” event at Kirchhoff Field
Researchers from the Project ALS Therapeutics Core at Columbia (the Core), in a groundbreaking collaborative effort with Ionis Pharmaceuticals, have developed a new tool for studying ALS mechanisms and therapies, as well as a novel approach for treating ALS caused by mutations…
“I was diagnosed with ALS in February 2020 after a frustrating year of searching for answers & even longer of progressing symptoms…”
Temporary Mailing Address:
4330 Camp Kaufmann Road
Huntingtown, MD 20639
801 Riverside Drive, Suite 6G
New York, NY 10032
Phone: (212) 420-7382
Fax: (646) 559-9290
Email: info@projectals.org
